Corcept Therapeutics

CA · United States · Reporting entity ID 100000000247

Total reported 2019–2025

$34.9M

#215 of 2,960 reporting companies — 0% of all reported industry payments

$16.9M in general payments across 154,341 records, plus $17.8M in research funding across 3,970 records.

How it breaks down

General payments $16,870,802

Research funding $17,830,304

Ownership & investment $234,410

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.